| Year |
Citation |
Score |
| 2006 |
Zucker BG, Craske MG, Blackmore MA, Nitz A. A cognitive behavioral workshop for subclinical obsessions and compulsions. Behaviour Research and Therapy. 44: 289-304. PMID 16376296 DOI: 10.1016/J.Brat.2005.03.015 |
0.639 |
|
| 2005 |
Tsao JC, Mystkowski JL, Zucker BG, Craske MG. Impact of cognitive-behavioral therapy for panic disorder on comorbidity: a controlled investigation. Behaviour Research and Therapy. 43: 959-70. PMID 15896289 DOI: 10.1016/J.Brat.2004.11.013 |
0.729 |
|
| 2002 |
Hazlett-Stevens H, Zucker BG, Craske MG. The relationship of thought-action fusion to pathologicial worry and generalized anxiety disorder. Behaviour Research and Therapy. 40: 1199-204. PMID 12375728 DOI: 10.1016/S0005-7967(01)00138-3 |
0.628 |
|
| 2002 |
Craske MG, Lang AJ, Mystkowski JL, Zucker BG, Bystritsky A, Yan-Go F. Does nocturnal panic represent a more severe form of panic disorder? The Journal of Nervous and Mental Disease. 190: 611-8. PMID 12357095 DOI: 10.1097/00005053-200209000-00006 |
0.675 |
|
| 2002 |
Zucker BG, Craske MG, Barrios V, Holguin M. Thought action fusion: can it be corrected? Behaviour Research and Therapy. 40: 653-64. PMID 12051484 DOI: 10.1016/S0005-7967(01)00054-7 |
0.534 |
|
| 2002 |
Tsao JCI, Mystkowski JL, Zucker BG, Craske MG. Effects of cognitive-behavioral therapy for panic disorder on comorbid conditions: Replication and extension Behavior Therapy. 33: 493-509. DOI: 10.1016/S0005-7894(02)80013-2 |
0.748 |
|
| 2002 |
Tsao JCI, Mystkowski JL, Zucker BG, Craske MG. Effects of cognitive-behavioral therapy for panic disorder on comorbid conditions: Replication and extension Behavior Therapy. 33: 493-509. DOI: 10.1016/S0005-7894(02)80013-2 |
0.748 |
|
| 2001 |
Craske MG, Zucker BG. Prevention of anxiety disorders: A model for intervention Applied and Preventive Psychology. 10: 155-175. DOI: 10.1016/S0962-1849(01)80012-3 |
0.675 |
|
| 2001 |
Craske MG, Zucker BG. Consideration of the APA practice guideline for the treatment of patients with panic disorder: Strengths and limitations for behavior therapy Behavior Therapy. 32: 259-281. DOI: 10.1016/S0005-7894(01)80005-8 |
0.676 |
|
| 2001 |
Craske MG, Zucker BG. Prevention of anxiety disorders: A model for intervention Applied and Preventive Psychology. 10: 155-175. |
0.468 |
|
| 2001 |
Craske MG, Zucker BG. Prevention of anxiety disorders: A model for intervention Applied and Preventive Psychology. 10: 155-175. |
0.468 |
|
| 2001 |
Craske MG, Zucker BG. Consideration of the APA practice guideline for the treatment of patients with panic disorder: Strengths and limitations for behavior therapy Behavior Therapy. 32: 259-281. |
0.5 |
|
| 2001 |
Craske MG, Zucker BG. Consideration of the APA practice guideline for the treatment of patients with panic disorder: Strengths and limitations for behavior therapy Behavior Therapy. 32: 259-281. |
0.5 |
|
| 1999 |
Otto MW, Pollack MH, Penava SJ, Zucker BG. Group cognitive-behavior therapy for patients failing to respond to pharmacotherapy for panic disorder: a clinical case series. Behaviour Research and Therapy. 37: 763-70. PMID 10452176 DOI: 10.1016/S0005-7967(98)00176-4 |
0.51 |
|
| 1997 |
Wilhelm S, Otto MW, Zucker BG, Pollack MH. Prevalence of body dysmorphic disorder in patients with anxiety disorders. Journal of Anxiety Disorders. 11: 499-502. PMID 9407269 DOI: 10.1016/S0887-6185(97)00026-1 |
0.617 |
|
| 1997 |
Pollack MH, Worthington JJ, Manfro GG, Otto MW, Zucker BG. Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone. The Journal of Clinical Psychiatry. 58: 19-23. PMID 9363044 |
0.544 |
|
| Show low-probability matches. |